{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:42:32Z","timestamp":1792896152099,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In 474 genome sequenced <jats:italic>Pseudomonas aeruginosa<\/jats:italic> isolates from 34 cystic fibrosis (CF) patients, 40% of these harbor mutations in the <jats:italic>mexZ<\/jats:italic> gene encoding a negative regulator of the MexXY-OprM efflux pump associated with aminoglycoside and fluoroquinolone resistance. Surprisingly, resistance to aminoglycosides and fluoroquinolones of <jats:italic>mexZ<\/jats:italic> mutants was far below the breakpoint of clinical resistance. However, the fitness increase of the mutant bacteria in presence of the relevant antibiotics, as demonstrated in competition experiments between mutant and ancestor bacteria, showed that 1) very small phenotypic changes cause significant fitness increase with severe adaptive consequences, and 2) standardized phenotypic tests fail to detect such low-level variations. The frequent appearance of <jats:italic>P. aeruginosa mexZ<\/jats:italic> mutants in CF patients is directly connected to the intense use of the target antibiotics, and low-level antibiotic resistance, if left unnoticed, can result in accumulation of additional genetic changes leading to high-level resistance.<\/jats:p>","DOI":"10.1038\/s41598-018-30972-y","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T10:59:17Z","timestamp":1534330757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts"],"prefix":"10.1038","volume":"8","author":[{"given":"Jakob","family":"Frimodt-M\u00f8ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2042-608X","authenticated-orcid":false,"given":"Elio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus Anders Juul","family":"Haagensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7838-7258","authenticated-orcid":false,"given":"Marilena","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-3717","authenticated-orcid":false,"given":"Helle Krogh","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"key":"30972_CR1","doi-asserted-by":"publisher","first-page":"e01592","DOI":"10.1128\/mBio.01592-14","volume":"5","author":"T Markussen","year":"2014","unstructured":"Markussen, T. et al. Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa. MBio 5, e01592\u201301514, https:\/\/doi.org\/10.1128\/mBio.01592-14 (2014).","journal-title":"MBio"},{"key":"30972_CR2","doi-asserted-by":"publisher","first-page":"e1003741","DOI":"10.1371\/journal.pgen.1003741","volume":"9","author":"RL Marvig","year":"2013","unstructured":"Marvig, R. L., Johansen, H. K., Molin, S. & Jelsbak, L. Genome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet 9, e1003741, https:\/\/doi.org\/10.1371\/journal.pgen.1003741 (2013).","journal-title":"PLoS Genet"},{"key":"30972_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jcf.2012.02.006","volume":"11","author":"MN Hurley","year":"2012","unstructured":"Hurley, M. N., Ariff, A. H., Bertenshaw, C., Bhatt, J. & Smyth, A. R. Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis. J Cyst Fibros 11, 288\u2013292, https:\/\/doi.org\/10.1016\/j.jcf.2012.02.006 (2012).","journal-title":"J Cyst Fibros"},{"key":"30972_CR4","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1378\/chest.123.5.1495","volume":"123","author":"AL Smith","year":"2003","unstructured":"Smith, A. L., Fiel, S. B., Mayer-Hamblett, N., Ramsey, B. & Burns, J. L. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 123, 1495\u20131502 (2003).","journal-title":"Chest"},{"key":"30972_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ng.3148","volume":"47","author":"RL Marvig","year":"2015","unstructured":"Marvig, R. L., Sommer, L. M., Molin, S. & Johansen, H. K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet 47, 57\u201364, https:\/\/doi.org\/10.1038\/ng.3148 (2015).","journal-title":"Nat Genet"},{"key":"30972_CR6","doi-asserted-by":"publisher","unstructured":"Feliziani, S. et al. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections. PLoS One 5, https:\/\/doi.org\/10.1371\/journal.pone.0012669 (2010).","DOI":"10.1371\/journal.pone.0012669"},{"key":"30972_CR7","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1073\/pnas.0602138103","volume":"103","author":"EE Smith","year":"2006","unstructured":"Smith, E. E. et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 103, 8487\u20138492, https:\/\/doi.org\/10.1073\/pnas.0602138103 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"30972_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1139\/cjm-2017-0380","volume":"63","author":"M Singh","year":"2017","unstructured":"Singh, M., Yau, Y. C. W., Wang, S., Waters, V. & Kumar, A. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections. Can J Microbiol 63, 929\u2013938, https:\/\/doi.org\/10.1139\/cjm-2017-0380 (2017).","journal-title":"Can J Microbiol"},{"key":"30972_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/j.1469-0691.2011.03530.x","volume":"17","author":"AB Campo Esquisabel","year":"2011","unstructured":"Campo Esquisabel, A. B., Rodriguez, M. C., Campo-Sosa, A. O., Rodriguez, C. & Martinez-Martinez, L. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime. Clin Microbiol Infect 17, 1817\u20131822, https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03530.x (2011).","journal-title":"Clin Microbiol Infect"},{"key":"30972_CR10","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.1128\/AAC.00724-16","volume":"60","author":"L Greipel","year":"2016","unstructured":"Greipel, L. et al. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients. Antimicrob Agents Chemother 60, 6726\u20136734, https:\/\/doi.org\/10.1128\/AAC.00724-16 (2016).","journal-title":"Antimicrob Agents Chemother"},{"key":"30972_CR11","doi-asserted-by":"publisher","first-page":"e29276","DOI":"10.1371\/journal.pone.0029276","volume":"6","author":"Q Wei","year":"2011","unstructured":"Wei, Q. et al. Phenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosa. PLoS One 6, e29276, https:\/\/doi.org\/10.1371\/journal.pone.0029276 (2011).","journal-title":"PLoS One"},{"key":"30972_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.femsle.2004.07.010","volume":"238","author":"Y Matsuo","year":"2004","unstructured":"Matsuo, Y., Eda, S., Gotoh, N., Yoshihara, E. & Nakae, T. MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol Lett 238, 23\u201328, https:\/\/doi.org\/10.1016\/j.femsle.2004.07.010 (2004).","journal-title":"FEMS Microbiol Lett"},{"key":"30972_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fmicb.2011.00065","volume":"2","author":"K Poole","year":"2011","unstructured":"Poole, K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2, 65, https:\/\/doi.org\/10.3389\/fmicb.2011.00065 (2011).","journal-title":"Front Microbiol"},{"key":"30972_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/CMR.00040-09","volume":"22","author":"PD Lister","year":"2009","unstructured":"Lister, P. D., Wolter, D. J. & Hanson, N. D. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22, 582\u2013610, https:\/\/doi.org\/10.1128\/CMR.00040-09 (2009).","journal-title":"Clin Microbiol Rev"},{"key":"30972_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1128\/AAC.01252-13","volume":"58","author":"S Guenard","year":"2014","unstructured":"Guenard, S. et al. Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 58, 221\u2013228, https:\/\/doi.org\/10.1128\/AAC.01252-13 (2014).","journal-title":"Antimicrob Agents Chemother"},{"key":"30972_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/thoraxjnl-2015-208027","volume":"72","author":"MH Prickett","year":"2017","unstructured":"Prickett, M. H. et al. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene. Thorax 72, 40\u201347, https:\/\/doi.org\/10.1136\/thoraxjnl-2015-208027 (2017).","journal-title":"Thorax"},{"key":"30972_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","volume":"16","author":"G Doring","year":"2000","unstructured":"Doring, G. et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 16, 749\u2013767 (2000).","journal-title":"Eur Respir J"},{"key":"30972_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jcf.2008.06.009","volume":"7","author":"CR Hansen","year":"2008","unstructured":"Hansen, C. R., Pressler, T. & Hoiby, N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros 7, 523\u2013530, https:\/\/doi.org\/10.1016\/j.jcf.2008.06.009 (2008).","journal-title":"J Cyst Fibros"},{"key":"30972_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jsb.2010.07.012","volume":"172","author":"Y Alguel","year":"2010","unstructured":"Alguel, Y., Lu, D., Quade, N., Sauter, S. & Zhang, X. Crystal structure of MexZ, a key repressor responsible for antibiotic resistance in Pseudomonas aeruginosa. J Struct Biol 172, 305\u2013310, https:\/\/doi.org\/10.1016\/j.jsb.2010.07.012 (2010).","journal-title":"J Struct Biol"},{"key":"30972_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fmicb.2012.00408","volume":"3","author":"Y Morita","year":"2012","unstructured":"Morita, Y., Tomida, J. & Kawamura, Y. MexXY multidrug efflux system of Pseudomonas aeruginosa. Front Microbiol 3, 408, https:\/\/doi.org\/10.3389\/fmicb.2012.00408 (2012).","journal-title":"Front Microbiol"},{"key":"30972_CR21","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints, http:\/\/www.eucast.org\/clinical_breakpoints\/ (2017)."},{"key":"30972_CR22","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jac\/46.6.885","volume":"46","author":"XZ Li","year":"2000","unstructured":"Li, X. Z., Barre, N. & Poole, K. Influence of the MexA-MexB-oprM multidrug efflux system on expression of the MexC-MexD-oprJ and MexE-MexF-oprN multidrug efflux systems in Pseudomonas aeruginosa. J Antimicrob Chemother 46, 885\u2013893 (2000).","journal-title":"J Antimicrob Chemother"},{"key":"30972_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/thx.52.6.557","volume":"52","author":"J Hull","year":"1997","unstructured":"Hull, J., Vervaart, P., Grimwood, K. & Phelan, P. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 52, 557\u2013560 (1997).","journal-title":"Thorax"},{"key":"30972_CR24","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s10096-014-2133-8","volume":"33","author":"FJ Reen","year":"2014","unstructured":"Reen, F. J. et al. Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 33, 1763\u20131771, https:\/\/doi.org\/10.1007\/s10096-014-2133-8 (2014).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"30972_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0092-8674(00)81099-5","volume":"85","author":"JJ Smith","year":"1996","unstructured":"Smith, J. J., Travis, S. M., Greenberg, E. P. & Welsh, M. J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229\u2013236 (1996).","journal-title":"Cell"},{"key":"30972_CR26","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1128\/AAC.01495-10","volume":"55","author":"S Fraud","year":"2011","unstructured":"Fraud, S. & Poole, K. Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55, 1068\u20131074, https:\/\/doi.org\/10.1128\/AAC.01495-10 (2011).","journal-title":"Antimicrob Agents Chemother"},{"key":"30972_CR27","doi-asserted-by":"publisher","unstructured":"Kirchner, S. et al. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung. J Vis Exp e3857, https:\/\/doi.org\/10.3791\/3857 (2012).","DOI":"10.3791\/3857"},{"key":"30972_CR28","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1128\/AAC.05037-14","volume":"59","author":"JA Haagensen","year":"2015","unstructured":"Haagensen, J. A., Verotta, D., Huang, L., Spormann, A. & Yang, K. New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms. Antimicrob Agents Chemother 59, 4074\u20134081, https:\/\/doi.org\/10.1128\/AAC.05037-14 (2015).","journal-title":"Antimicrob Agents Chemother"},{"key":"30972_CR29","doi-asserted-by":"publisher","unstructured":"Gomez, J. E. et al. Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment. Elife 6, https:\/\/doi.org\/10.7554\/eLife.20420 (2017).","DOI":"10.7554\/eLife.20420"},{"key":"30972_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2017.12.012","volume":"172","author":"L Imamovic","year":"2018","unstructured":"Imamovic, L. et al. Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections. Cell 172, 121\u2013134 e114, https:\/\/doi.org\/10.1016\/j.cell.2017.12.012 (2018).","journal-title":"Cell"},{"key":"30972_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169, https:\/\/doi.org\/10.1093\/bioinformatics\/btu638 (2015).","journal-title":"Bioinformatics"},{"key":"30972_CR32","doi-asserted-by":"publisher","first-page":"e93009","DOI":"10.1371\/journal.pone.0093009","volume":"9","author":"C Peano","year":"2014","unstructured":"Peano, C. et al. Gene and protein expression in response to different growth temperatures and oxygen availability in Burkholderia thailandensis. PLoS One 9, e93009, https:\/\/doi.org\/10.1371\/journal.pone.0093009 (2014).","journal-title":"PLoS One"},{"key":"30972_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/1462-2920.12309","volume":"16","author":"E Martinez-Garcia","year":"2014","unstructured":"Martinez-Garcia, E., Nikel, P. I., Chavarria, M. & de Lorenzo, V. The metabolic cost of flagellar motion in Pseudomonas putida KT2440. Environ Microbiol 16, 291\u2013303, https:\/\/doi.org\/10.1111\/1462-2920.12309 (2014).","journal-title":"Environ Microbiol"},{"key":"30972_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand, I., Hilpert, K. & Hancock, R. E. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3, 163\u2013175, https:\/\/doi.org\/10.1038\/nprot.2007.521 (2008).","journal-title":"Nat Protoc"},{"key":"30972_CR35","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/JCM.36.3.824-826.1998","volume":"36","author":"G Di Bonaventura","year":"1998","unstructured":"Di Bonaventura, G., Ricci, E., Della Loggia, N., Catamo, G. & Piccolomini, R. Evaluation of the E test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long-term bladder catheterization. J Clin Microbiol 36, 824\u2013826 (1998).","journal-title":"J Clin Microbiol"},{"key":"30972_CR36","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.1073\/pnas.1018249108","volume":"108","author":"L Yang","year":"2011","unstructured":"Yang, L. et al. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA 108, 7481\u20137486, https:\/\/doi.org\/10.1073\/pnas.1018249108 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"30972_CR37","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/35037572","volume":"407","author":"VS Cooper","year":"2000","unstructured":"Cooper, V. S. & Lenski, R. E. The population genetics of ecological specialization in evolving Escherichia coli populations. Nature 407, 736\u2013739, https:\/\/doi.org\/10.1038\/35037572 (2000).","journal-title":"Nature"},{"key":"30972_CR38","doi-asserted-by":"publisher","unstructured":"O\u2019Toole, G. A. Microtiter dish biofilm formation assay. J Vis Exp, https:\/\/doi.org\/10.3791\/2437 (2011).","DOI":"10.3791\/2437"},{"key":"30972_CR39","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/0091270003257225","volume":"43","author":"JL Kuti","year":"2003","unstructured":"Kuti, J. L., Dandekar, P. K., Nightingale, C. H. & Nicolau, D. P. Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem. J Clin Pharmacol 43, 1116\u20131123, https:\/\/doi.org\/10.1177\/0091270003257225 (2003).","journal-title":"J Clin Pharmacol"},{"key":"30972_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jcf.2006.12.007","volume":"6","author":"DJ Touw","year":"2007","unstructured":"Touw, D. J., Knox, A. J. & Smyth, A. Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis. J Cyst Fibros 6, 327\u2013333, https:\/\/doi.org\/10.1016\/j.jcf.2006.12.007 (2007).","journal-title":"J Cyst Fibros"},{"key":"30972_CR41","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1128\/AEM.68.4.2008-2017.2002","volume":"68","author":"A Heydorn","year":"2002","unstructured":"Heydorn, A. et al. Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-to-cell signaling, and stationary-phase sigma factor expression. Appl Environ Microbiol 68, 2008\u20132017 (2002).","journal-title":"Appl Environ Microbiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30972-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:51:10Z","timestamp":1671612670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30972-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30972"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30972-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"assertion":[{"value":"16 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12512"}}